Any article/agent used in the mitigation, diagnosis, prevention, treatment, and cure of diseases in man and in animals
Main divisions of pharmacology
Pharmacodynamics
Pharmacokinetics
Pharmacotherapeutics
Pharmacodynamics
Deals with the study of biochemical and physiologic effects of drugs in biological systems and the mechanisms by which these effects were produced
Pharmacokinetics
Study of fate and disposition of drugs in the body
Pharmacotherapeutics
Study of rational drug use in the management of certain diseases
General mechanisms by which drugs alter normal functions of cells
Interaction with receptors
Alteration of the activity of enzymes
Antimetabolite action
Non-specific chemical or physical interactions
Receptors
Naturally occurring target macromolecules which mediate actions of endogenous physiologic substances
Types of drug-receptor interactions
Type I
Type II
Type III
Type IV
Agonists are capable of binding to, and activating, a receptor
Full agonists occupy receptors to cause maximal activation
Partial agonists occupy receptors but cannot elicit a maximal response
Inverse agonists produce intrinsic activity <0
Antagonists bind to the receptor but do not initiate a response; block the action of an agonist or endogenous substance that works through the receptor
Competitive antagonists combine with the same receptor as the agonist
Non-competitive antagonists bind to the receptor at a site other than the agonist-binding site
Graded-dose response curve
Expresses an individual's response to increasing doses of a drug
Efficacy
Measure of the ability of a drug to elicit the MAXIMUM pharmacologic response
Potency
Relative measure of the ability of a drug to produce half of the maximum response
Ceiling dose
The smallest dose which produces the maximum response
Slope
Indicates changes in response; Steep curve implies a small change in dose produces a large change in response
Quantal-dose response curve
Relates the dosage of a drug to the frequency with which a designated response will occur within a population
Autonomic Nervous System (ANS)
Subdivision of the peripheral efferent nervous system; controls involuntary activity
Divisions of the ANS
Parasympathetic Nervous System
Sympathetic Nervous System
Enteric Nervous System
Synaptic transmission
Mechanism of impulse across the synapse
Differences between Sympathetic and Parasympathetic Nervous Systems
Preganglionic neuron location
Neurotransmitter
Receptor type
Physiological effects
Catecholamines
Possess a catechol nucleus and an ethylamine side chain; include Norepinephrine, Epinephrine, Dopamine
Catecholamine biosynthesis
1. Tyrosine
2. DOPA
3. Dopamine
4. Norepinephrine
5. Epinephrine
Catecholamine storage and release
Stored in vesicles
Released from nerve terminals through calcium-dependent exocytosis
Blocked by reserpine
Enhanced by tyramine, ephedrine, amphetamine
Inhibited by guanethidine, guanadrel, bretylium
Catecholamine termination mechanisms
Reuptake
Diffusion
Metabolism via COMT and MAO
Sympathetic receptor types
Alpha-1
Alpha-2
Beta-1
Beta-2
Sympathomimetic drug classifications
Direct-acting
Indirect-acting
Mixed-acting
Sympathomimetics
Mimic the effects of endogenous catecholamines (NE, EPI)
Sympathomimetic drug examples
Epinephrine
Norepinephrine
Dopamine
Isoproterenol
Dobutamine
Terbutaline, Albuterol, Metaproterenol, etc.
Phenylephrine, Methoxamine, Metaraminol
Clonidine, Methyldopa, Guanabenz, Guanfacine
Ephedrine, Mephentermine
Amphetamine, Dextroamphetamine, etc.
Sympathomimetic therapeutic uses
Cardiovascular
Respiratory
Eye
CNS
Other
Sympatholytics
Prevent or reverse the actions of endogenously released NE or EPI or exogenously administered sympathomimetic agents